Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study

Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study

ABSTRACT: Objectives: This study aimed to determine the prevalence of latent tuberculosis infection (LTBI) in immigrant children and adolescents (aged 0-17 years) living or recently arriving in Sweden. It also aimed to estimate the effectiveness of Bacillus Calmette-Guérin (BCG) against LTBI in imm...

Full description

Bibliographic Details
Main Authors:	Birger Trollfors, MD, Vignir Sigurdsson, MD, Anna Dahlgren-Aronsson, MD
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Series:	International Journal of Infectious Diseases
Subjects:	BCG Latent tuberculosis Vaccine effectiveness
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971221005348

Similar Items

BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells
by: Harindra D. Sathkumara, et al.
Published: (2019-03-01)

Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda
by: Lawrence Lubyayi, et al.
Published: (2020-05-01)

Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth
by: Dagnew Alemnew F, et al.
Published: (2012-08-01)

Features of the development of tuberculosis in children not vaccinated with BCG
by: O. M. Raznatovska, et al.
Published: (2018-07-01)

DIFFERENT CHARACTERISTICS OF INFECTION WITH MYCOBACTERIA IN GRANULOMA CELLS FROM MICE WITH LATENT TUBERCULOSIS INFECTION AND IN BONE MARROW AND PERITONEAL MACROPHAGES AFTER BCG VACCINE APPLICATION IN VITRO
by: E. G. Ufimtseva
Published: (2014-08-01)

Contemporary aspects of tuberculosis in children without BCG vaccination
by: M. N. Kondаkovа, et al.
Published: (2021-04-01)

Vaccination against M. tuberculosis – what next after BCG?
by: Marek Fol, et al.
Published: (2011-01-01)

BCG Vaccine Protection against TB Infection among Children Older than 5 Years in Close Contact with an Infectious Adult TB Case
by: Angeliki Syggelou, et al.
Published: (2020-10-01)

COMPARATIVE ANALYSIS OF THE FREQUENCY AND STRUCTURE OF COMPLICATIONS OF THE BCG AND BCG-M TUBERCULOSIS VACCINE
by: Pozdnyakova A. S.
Published: (2021-03-01)

Difference in Severity of Tuberculosis in Children with or without a BCG Scar
by: Gunadi Santosa, et al.
Published: (2019-04-01)

Mantoux test results and BCG vaccination status in TB-exposed children
by: Fadilah Harahap, et al.
Published: (2015-03-01)

Vacina BCG contra tuberculose: efeito protetor e políticas de vacinação BCG vaccine against tuberculosis: its protective effect and vaccination policies
by: Susan M Pereira, et al.
Published: (2007-09-01)

Nuevas herramientas para la detección de la tuberculosis latente.
by: Blanca I. Restrepo
Published: (2004-06-01)

Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations
by: Shalini Pooransingh, et al.
Published: (2020-03-01)

Osteíte por BCG Osteitis after BCG vaccination
by: André Fukunishi Yamada, et al.
Published: (2009-03-01)

Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine
by: Nancy Gupta, et al.
Published: (2018-10-01)

How to avoid the impact of environmental mycobacteria towards the efficacy of BCG vaccination against tuberculosis?
by: Om Parkash
Published: (2014-01-01)

Estimativa do risco de infecção tuberculosa em populações vacinadas pelo BCG Determining the risk of tuberculosis infection in BCG-vaccinated populations
by: Gilberto Ribeiro Arantes, et al.
Published: (1992-04-01)

The BCGΔBCG1419c Vaccine Candidate Reduces Lung Pathology, IL-6, TNF-α, and IL-10 During Chronic TB Infection
by: Mario A. Flores-Valdez, et al.
Published: (2018-06-01)

Nonclinical Development of BCG Replacement Vaccine Candidates
by: Bernd Eisele, et al.
Published: (2013-04-01)

Cost-Effectiveness Analysis of BCG Vaccination against Tuberculosis in Indonesia: A Model-Based Study
by: Afifah Machlaurin, et al.
Published: (2020-11-01)

Bacille Calmette–Guérin (BCG) Vaccine Induced Tuberculous Lymphadenitis: A Case Report
by: Kalyan Sapkota
Published: (2020-12-01)

Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland
by: Eileen Sweeney, et al.
Published: (2019-05-01)

Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats
by: Enric Vidal, et al.
Published: (2017-08-01)

PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION
by: V. V. Yeremeev, et al.
Published: (2019-07-01)

PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION
by: Vladimir Yeremeev, et al.
Published: (2019-03-01)

Current and Novel Approaches to Vaccine Development Against Tuberculosis
by: Mark eCayabyab, et al.
Published: (2012-12-01)

Therapeutic Approach in Complications of BCG Vaccinations in Children
by: I.P. Zhurilo, et al.
Published: (2013-05-01)

Commentary: Bettering BCG: a tough task for a TB vaccine?
by: Brahm S. Srivastava, et al.
Published: (2019-09-01)

Advances in the characterization of a proteol iposome derived from Mycobacterium bovis BCG as vaccine candidate against tuberculosis
by: Nadine Alvarez-Cabrera, et al.
Published: (2014-12-01)

BCG: The waning of a vaccine
by: Ashfaq Hasan
Published: (2014-02-01)

Changes in the BCG-Induced T cell response over the first year of life
by: Soares, Andreia
Published: (2015)

Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen
by: Nicolas Bruffaerts, et al.
Published: (2014-03-01)

Complications after BCG vaccination in a big city
by: T. A. Sevostyanova, et al.
Published: (2016-06-01)

Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG
by: Gil R. Diogo, et al.
Published: (2019-06-01)

The prevalence of latent tuberculosis (TB) infection in healthcare staff of Khorramabad Ashayer hospital in 2015
by: mohammad reza Nazer, et al.
Published: (2015-09-01)

In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection
by: Hyejon Lee, et al.
Published: (2019-04-01)

A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette–Guérin (BCG) against Mycobacterium tuberculosis
by: Sudeep Kumar Maurya, et al.
Published: (2020-09-01)

Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting
by: Shahieda Adams, et al.
Published: (2019-08-01)

Update on TB Vaccine Pipeline
by: Carlos Martin, et al.
Published: (2020-04-01)